Results 91 to 100 of about 15,215 (194)

Characterization of novel selective positive allosteric modulators (PAMS) of the M4 muscarinic acetylcholine receptor (mAChR)

open access: yesThe FASEB Journal, 2008
Resent clinical studies have revealed that the M 1 /M 4 preferring mAChR agonist xanomeline induces a robust antipsychotic effect in schizophrenic patients, suggesting that mAChR agonists may be efficacious in reducing psychotic symptoms in patients ...
Ashley Elizabeth Brady   +5 more
openaire   +1 more source

Modulation of large rhythmic depolarizations in human large basket cells by norepinephrine and acetylcholine

open access: yesCommunications Biology
Rhythmic brain activity is critical to many brain functions and is sensitive to neuromodulation, but so far very few studies have investigated this activity on the cellular level in vitro in human brain tissue samples.
Danqing Yang   +7 more
doaj   +1 more source

Clozapine is responsible for the in vivo imaging and pharmacological effects of clozapine-N-oxide in murine DREADD models

open access: yesFrontiers in Pharmacology
Although clozapine-N-oxide (CNO), a major metabolite of clozapine (CLZ), is a widely used agonist of designer receptors exclusively activated by designer drugs (DREADDs), the compound responsible for visualizing or activating DREADDs in nuclear medicine ...
Jian Wang   +14 more
doaj   +1 more source

555. M4 MUSCARINIC RECEPTOR ACTIVATION IN THE CENTRAL AMYGDALA REDUCES STRESS-INDUCED ALCOHOL SEEKING IN ALCOHOL PREFERRING RATS [PDF]

open access: yesInt J Neuropsychopharmacol
Background Stress is a key factor contributing to relapse, a major hurdle in the treatment of alcohol use disorders. A region key to brain stress systems and essential for emotional regulation is the central amygdala, and alcohol dependence has been ...
R. Anversa   +3 more
europepmc   +2 more sources

In vitro evaluation of PET radiotracers for imaging synaptic density, the acetylcholine transporter, AMPA-tarp-γ8 and muscarinic M4 receptors in Alzheimer's disease.

open access: yesAmerican Journal of Nuclear Medicine and Molecular Imaging
Several therapeutics and biomarkers that target Alzheimer's disease (AD) are under development. Our clinical positron emission tomography (PET) research programs are interested in six radiopharmaceuticals to image patients with AD and related dementias ...
Faustine d'Orchymont   +6 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy